Envveno Medical Corp Stock Total Asset
| NVNO Stock | USD 2.86 0.01 0.35% |
enVVeno Medical Corp fundamentals help investors to digest information that contributes to EnVVeno Medical's financial success or failures. It also enables traders to predict the movement of EnVVeno Stock. The fundamental analysis module provides a way to measure EnVVeno Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EnVVeno Medical stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 45 M | 23.9 M | |
| Intangibles To Total Assets | 0.22 | 0.20 |
EnVVeno | Total Asset |
enVVeno Medical Corp Company Total Asset Analysis
EnVVeno Medical's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current EnVVeno Medical Total Asset | 44.95 M |
Most of EnVVeno Medical's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, enVVeno Medical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
EnVVeno Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for EnVVeno Medical is extremely important. It helps to project a fair market value of EnVVeno Stock properly, considering its historical fundamentals such as Total Asset. Since EnVVeno Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EnVVeno Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EnVVeno Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
EnVVeno Total Asset Historical Pattern
Today, most investors in EnVVeno Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various EnVVeno Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of EnVVeno Medical total asset as a starting point in their analysis.
EnVVeno Medical Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
EnVVeno Total Assets
Total Assets |
|
Based on the latest financial disclosure, enVVeno Medical Corp has a Total Asset of 44.95 M. This is 99.4% lower than that of the Health Care Equipment & Supplies sector and 99.29% lower than that of the Health Care industry. The total asset for all United States stocks is 99.85% higher than that of the company.
EnVVeno Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EnVVeno Medical's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EnVVeno Medical could also be used in its relative valuation, which is a method of valuing EnVVeno Medical by comparing valuation metrics of similar companies.EnVVeno Medical is currently under evaluation in total asset category among its peers.
EnVVeno Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of EnVVeno Medical from analyzing EnVVeno Medical's financial statements. These drivers represent accounts that assess EnVVeno Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of EnVVeno Medical's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 11.2M | 57.2M | 57.3M | 63.2M | 56.9M | 59.7M | |
| Enterprise Value | 2.7M | 4.5M | 54.4M | 61.0M | 54.9M | 57.7M |
EnVVeno Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EnVVeno Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EnVVeno Medical's managers, analysts, and investors.Environmental | Governance | Social |
EnVVeno Medical Institutional Holders
Institutional Holdings refers to the ownership stake in EnVVeno Medical that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of EnVVeno Medical's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing EnVVeno Medical's value.| Shares | Northern Trust Corp | 2024-12-31 | 56.7 K | Hohimer Wealth Management, Llc | 2024-12-31 | 51.3 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 48.8 K | Squarepoint Ops Llc | 2024-12-31 | 47.9 K | State Street Corp | 2024-12-31 | 40.8 K | Blackrock Inc | 2024-12-31 | 40.6 K | Quadrature Capital Llp | 2024-12-31 | 39.2 K | Fermata Advisors, Llc | 2024-12-31 | 35.7 K | Virtu Financial Llc | 2024-12-31 | 28.5 K | Kingdon Capital Management Llc | 2024-12-31 | 859.3 K | Nantahala Capital Management, Llc | 2024-12-31 | 596.9 K |
EnVVeno Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | 9.29 M | ||||
| Shares Outstanding | 17.54 M | ||||
| Shares Owned By Insiders | 0.80 % | ||||
| Shares Owned By Institutions | 24.37 % | ||||
| Number Of Shares Shorted | 427.14 K | ||||
| Price To Book | 1.22 X | ||||
| EBITDA | (23.83 M) | ||||
| Net Income | (21.82 M) | ||||
| Cash And Equivalents | 37.48 M | ||||
| Cash Per Share | 3.96 X | ||||
| Total Debt | 1.06 M | ||||
| Debt To Equity | 0.04 % | ||||
| Current Ratio | 20.79 X | ||||
| Book Value Per Share | 2.40 X | ||||
| Cash Flow From Operations | (16.84 M) | ||||
| Short Ratio | 5.40 X | ||||
| Earnings Per Share | (1.27) X | ||||
| Target Price | 16.5 | ||||
| Number Of Employees | 37 | ||||
| Beta | 1.38 | ||||
| Market Capitalization | 49.98 M | ||||
| Total Asset | 44.95 M | ||||
| Retained Earnings | (151.85 M) | ||||
| Working Capital | 41.64 M | ||||
| Net Asset | 44.95 M |
About EnVVeno Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze enVVeno Medical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EnVVeno Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of enVVeno Medical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock: Check out EnVVeno Medical Piotroski F Score and EnVVeno Medical Altman Z Score analysis. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.